Adaptive Biotechnologies To Participate In Upcoming Investor Conferences

(MENAFN- GlobeNewsWire - Nasdaq) SEATTLE, May 21, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the following investor conferences.

• Craig-Hallum 23 ^rd Annual Institutional Investor Conference – Minneapolis, MN
  Hosting 1x1 meetings on Thursday, May 28^th
• William Blair 46 ^th Annual Growth Stock Conference – Chicago, IL
  Presentation on Wednesday, June 3^rd at 3:20 p.m. Central Time
  

Interested parties may access a live and archived webcast of the presentation from the William Blair Growth Stock Conference on the“Investors” section of the company website at: .

About Adaptive Biotechnologies

Adaptive Biotechnologies (“we” or“our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature's most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business segments: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer and autoimmune disorders. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.

ADAPTIVE INVESTORS
Karina Calzadilla, Vice President, Investor Relations and FP&A
201-396-1687
...

ADAPTIVE MEDIA
Erica Jones, Associate Corporate Communications Director
206-279-2423
...

MENAFN21052026004107003653ID1111152935